Aquestive Therapeutics, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Aquestive Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2023.
  • Aquestive Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $81.7M.
  • Aquestive Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $3.97M, a 65.7% decline from 2022.
  • Aquestive Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $11.6M, a 61.5% decline from 2021.
  • Aquestive Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $30.1M, a 5.81% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.97M -$7.62M -65.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $11.6M -$18.5M -61.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $30.1M +$1.65M +5.81% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $28.5M -$21.1M -42.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-08
2019 $49.6M -$8.44M -14.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 $58M +$53.6M +1215% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-11
2017 $4.41M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.